pulmonari
fibrosi
pf
common
complic
interstiti
lung
diseas
patient
result
poor
prognosi
short
surviv
tradit
therapeut
method
glucocorticoid
cytotox
drug
insuffici
treat
pf
may
caus
sever
side
effect
recent
studi
show
tradit
chines
herbal
abstract
tanshinon
iia
tiia
display
signific
antipf
effect
anim
model
howev
exact
mechan
underli
protect
effect
tiia
fulli
understood
investig
protect
effect
tiia
mechan
underli
pf
model
rat
induc
bleomycin
blm
tiia
administ
subsequ
pf
chang
identifi
histopatholog
analys
result
show
blm
result
sever
pf
alveolar
inflamm
togeth
signific
elev
transform
growth
angiotensinconvert
enzym
togeth
angiotensin
ang
greatli
reduc
blm
administr
tiia
treatment
notabl
attenu
blm
induc
pf
inflamm
decreas
express
revers
ang
product
rat
lung
thu
may
draw
conclus
tiia
may
exert
protect
effect
blm
induc
pf
rat
axi
may
ascrib
protect
effect
idiopath
pulmonari
fibrosi
ipf
fatal
interstiti
lung
diseas
character
rapidli
progress
scar
lung
tissu
togeth
exacerb
fibroblast
prolifer
excess
accumul
matrix
protein
destruct
alveolar
structur
chang
gradual
result
loss
lung
function
ultim
respiratori
failur
ipf
agerel
diseas
poor
prognosi
median
surviv
ipf
patient
diseas
diagnosi
death
usual
year
exact
etiolog
ipf
still
unclear
limit
proven
treatment
opivyspr
intern
publish
tion
current
therapi
antiinflammatori
immunosuppress
antifibrot
method
show
promis
result
halt
progress
diseas
improv
qualiti
life
therefor
urgent
investig
pathophysiolog
mechan
explor
novel
therapeut
strategi
treat
pf
recent
studi
show
renin
angiotensin
system
ra
involv
progress
pf
evidenc
angiotensinogen
agt
gene
polymorph
associ
pf
overexpress
patient
pf
cleav
angiotensin
convert
enzym
ace
angiotensin
ang
turn
ang
ii
activ
ang
ii
answer
upregul
transform
growth
pivot
modul
differenti
fibroblast
myofibroblast
moreov
ang
ii
also
believ
associ
inflammatori
respons
cell
apoptosi
progress
variou
lung
diseas
recent
discoveri
homologu
ace
name
enzymat
product
ang
could
counter
detriment
effect
ace
offer
benefici
effect
limit
angii
accumul
kind
pathophysiolog
process
studi
also
demonstr
play
key
neg
regulatori
factor
sever
lung
edema
acut
lung
failur
recent
protect
effect
progress
pf
increasingli
investig
previou
studi
shown
tradit
chines
herbal
abstract
tanshinon
iia
tiia
exert
signific
protect
effect
lung
injuri
induc
lipopolysaccharid
lp
hypox
hypertens
present
studi
explor
tiia
protect
effect
employ
pf
model
rat
axi
investig
present
studi
tiia
shown
effect
halt
develop
pf
may
via
axi
studi
provid
new
insight
mechan
underli
lung
benefici
effect
tiia
may
offer
new
target
treat
pf
procedur
involv
anim
approv
anim
care
use
committe
fourth
militari
medic
univers
compli
declar
nation
institut
health
guid
care
use
laboratori
anim
public
revis
male
spraguedawley
rat
bodi
weight
g
anim
center
fourth
militari
medic
univers
xian
china
use
experi
studi
rat
randomli
divid
control
group
blm
group
blm
tiia
group
total
group
anesthet
rat
weight
blm
sigma
aldrich
st
loui
mo
administ
intratrach
dose
mgkg
volum
blm
tiia
mgkg
administ
intraperiton
daili
day
blm
given
hour
control
anim
inject
intratrach
steril
salin
blm
salin
given
lung
coeffici
weight
wet
lung
mg
bodi
weight
index
evalu
lung
edema
word
end
time
point
day
day
day
separ
rat
anesthet
sternotomi
surgeri
perform
lung
care
obtain
lung
clean
cold
pb
solut
lung
sip
filter
paper
lung
coeffici
calcul
part
right
lung
cut
next
histolog
assay
remain
maintain
freezer
next
analys
taken
lung
dissect
slice
part
lower
lobe
right
lung
fix
formaldehyd
lung
embed
paraffin
section
section
hematoxylin
eosin
stain
trichrom
masson
stain
perform
aim
evalu
collagen
fibrosi
chang
pf
modifi
picrosiriu
procedur
base
classic
siriu
red
stain
perform
brief
regular
deparaffin
rehydr
lung
specimen
immers
phosphomolybd
acid
min
cover
wv
siriu
red
sigmaaldrich
st
loui
mo
usa
satur
picric
acid
solut
h
room
temperatur
specimen
mount
dehydr
clear
xylen
specimen
analyz
use
light
microscop
olympu
tokyo
japan
normal
polar
light
obtain
polar
filter
olympu
uant
tokyo
japan
order
analyz
initi
collagen
organ
fibrosi
lung
alveolar
inflamm
pf
scale
stain
trichrom
masson
stain
describ
previou
studi
szapiel
three
independ
pathologist
undertook
histolog
examin
appli
score
system
blind
fashion
lung
section
prepar
deparaffin
rehydr
block
incub
h
min
antigen
retriev
perform
slide
incub
h
normal
goat
serum
incub
mous
monoclon
antibodi
mous
monoclon
antibodi
ang
mous
monoclon
antibodi
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
overnight
wash
phosphat
buffer
salin
pb
tissu
incub
correspond
antibodi
min
diaminobenzidin
dab
signal
detect
method
perform
min
room
temperatur
neg
control
perform
use
mous
serum
primari
antibodi
posit
stain
color
deep
brown
section
evalu
use
olympu
optic
microscop
equip
imag
analysi
program
imag
pro
plu
version
immagini
e
comput
milan
itali
analyz
quantit
integr
optic
densiti
iod
calcul
arbitrari
area
measur
field
sampl
use
object
rat
lung
tissu
homogen
use
liquid
nitrogen
total
lysat
obtain
rat
lung
tissu
ripa
lysi
buffer
beyotim
inc
jiangsu
china
equival
amount
protein
sampl
separ
electrophoresi
use
sdspolyacrylamid
gel
transfer
onto
nitrocellulos
filter
membran
block
skim
milk
band
incub
correspond
primari
antibodi
total
rna
rat
lung
tissu
extract
use
trizol
agent
invitrogen
carlsbad
ca
usa
firststrand
cdna
synthes
mmlv
revers
transcripas
kit
bestbio
inc
shanghai
china
per
sampl
total
rna
accord
manufactur
instruct
primer
pair
design
primer
premier
premier
biosoft
intern
palo
alto
ca
usa
origin
inform
cdna
align
genebank
primer
check
synthes
genescript
compani
nangj
china
primer
pair
gaagacatgaccctgctggtga
forward
chain
ctggtgctctgggcacttga
revers
chain
aatcgtaggctctgggcttgg
forward
chain
ttcgatcaactggtttcggttgta
revers
chain
concentr
ang
lung
tissu
measur
use
elisa
kit
r
system
inc
mn
usa
accord
manufactur
instruct
data
express
mean
sd
statist
analysi
perform
analysi
varianc
anova
statist
differ
accept
signific
p
accord
evalu
scale
blm
exposur
result
signific
drop
rat
weight
notabl
increas
lung
coeffici
compar
control
group
p
tabl
howev
tiia
treatment
significantli
revers
drop
weight
increas
lung
coeffici
rat
p
vs
blm
group
tabl
stain
show
intact
clear
alveoli
normal
interstitium
inflammatori
cell
observ
lung
control
group
time
point
fig
howev
blm
administr
caus
progress
lung
injuri
demonstr
destruct
lung
alveoli
inflammatori
cell
infiltr
thicken
lung
interstitium
time
extens
p
vs
control
group
tabl
fig
tiia
treatment
prevent
chang
rat
lung
administ
blm
p
vs
blm
group
tabl
fig
trichrom
masson
stain
also
show
intact
alveoli
normal
interstitium
lung
control
group
time
point
fig
blm
administr
result
gradual
exacerb
lung
alveoli
destruct
interstitium
thicken
fibroblast
diffus
rat
lung
p
vs
control
group
tabl
fig
tiia
treatment
significantli
halt
chang
rat
lung
blm
administr
time
point
p
vs
blm
group
tabl
fig
siriu
red
stain
exhibit
collagen
fiber
type
stain
orang
red
color
type
iii
collagen
fiber
stain
yellow
green
color
found
rat
lung
control
group
fig
signific
chang
time
point
howev
blm
result
accumul
type
iii
collagen
fiber
rat
lung
time
elaps
p
vs
control
group
tabl
fig
tiia
treatment
significantli
allevi
chang
p
vs
blm
group
tabl
fig
immunohistochem
stain
show
blm
result
signific
decreas
express
rat
lung
compar
control
group
endpoint
day
p
fig
tiia
treatment
greatli
upregul
express
rat
lung
versu
blm
administ
group
p
fig
protein
level
verifi
wb
assay
data
show
protein
level
dramat
lessen
blm
administr
fig
howev
tiia
treatment
greatli
revers
lower
express
fig
similar
protein
express
rat
lung
mrna
level
also
notabl
decreas
administr
blm
compar
control
group
p
fig
howev
tiia
treatment
significantli
augment
express
mrna
rat
lung
p
fig
blm
administr
result
notabl
decreas
ang
express
rat
lung
compar
control
group
endpoint
day
p
fig
yet
tiia
treatment
obvious
increas
express
ang
blm
administr
p
vs
blm
group
fig
elisa
assay
verifi
blm
administr
contribut
decreas
ang
level
rat
lung
p
vs
control
group
fig
howev
tiia
treatment
revers
decreas
express
ang
p
vs
blm
group
fig
blm
administr
evid
increas
protein
level
compar
control
group
rat
lung
endpoint
day
p
howev
tiia
treatment
significantli
reduc
express
p
vs
blm
group
fig
protein
level
verifi
wb
assay
data
show
protein
level
dramat
elev
blm
administr
fig
howev
tiia
treatment
greatli
inhibit
express
fig
similarli
blm
administr
evid
increas
mrna
level
rat
lung
p
vs
control
group
fig
tiia
treatment
significantli
reduc
express
p
vs
blm
group
fig
present
studi
examin
protect
effect
tiia
blm
induc
pf
model
rat
blm
administr
result
progress
signific
inflamm
exacerb
fibrosi
sever
alveolar
destruct
rat
lung
addit
signific
decreas
ang
elev
also
found
rat
lung
blm
exposur
howev
tiia
treatment
notabl
halt
blm
induc
pf
inflamm
decreas
exagger
revers
reduct
ang
rat
lung
overal
result
suggest
protect
role
tiia
blm
induc
pf
rat
axi
may
answer
protect
role
tiia
pf
common
respons
lung
injuri
induc
variou
etiolog
etiolog
includ
ipf
acut
respiratori
distress
syndrom
ard
sarcoidosi
irradiationrel
pneumon
etc
interstiti
fibrosi
character
exagger
deposit
extracellular
matrix
protein
lung
endotheli
epitheli
cell
damag
due
lung
injuri
accumul
inflammatori
cell
subsequ
increas
product
inflammatori
mediat
togeth
promot
fibroblast
activ
prolifer
pathogenesi
pf
pf
induc
exacerb
prolifer
fibroblast
connect
tissu
expans
alveolar
destruct
gradual
lead
function
loss
lung
intract
diseas
pf
low
surviv
time
diagnosi
effect
therapi
till
today
understand
diseas
recent
aim
treat
pf
shift
revers
develop
slow
halt
progress
chronic
fibrot
diseas
well
known
amplifi
lung
injuri
play
key
promot
involv
convers
fibroblast
myofibroblast
transform
epitheli
cell
myofbroblast
epithelialmesenchym
transit
protect
myofbroblast
apoptosi
accumul
collagen
progress
pf
studi
demonstr
increas
level
lung
blm
exposur
monoclon
antibodi
demonstr
effect
block
murin
fibrosi
partial
inhibit
without
exacerb
inflamm
gene
therapi
method
reveal
choic
attenu
fibrogenesi
direct
indirect
block
signal
pathway
present
studi
endotrach
instil
blm
induc
sever
pf
togeth
dramat
increas
express
demonstr
accumul
interstiti
lung
collagen
collagen
deposit
obvious
decreas
tiia
treatment
line
studi
also
observ
increas
lung
mrna
level
blm
instil
significantli
reduc
tiia
treatment
homologu
ace
identifi
find
evok
new
complex
ra
despit
similar
function
ace
differ
substrat
previou
studi
reveal
may
neg
regul
ra
counterbal
function
ace
anoth
studi
also
demonstr
play
neg
regulatori
role
sever
lung
edema
acut
lung
failur
moreov
decreas
pulmonari
activ
relat
blm
induc
lung
injuri
report
anim
human
studi
studi
show
blm
induc
decreas
level
rat
lung
consist
previou
studi
moreov
tiia
treatment
revers
lower
express
level
immunohistochem
wb
assay
addit
mrna
level
also
significantli
lower
blm
exposur
also
agreement
studi
mention
ang
gener
singl
residu
cleav
ang
ii
ang
could
resist
mani
effect
ang
ii
also
potenti
bradykinin
action
subsequ
nitricoxidedepend
vasodil
studi
demonstr
ang
reduc
level
cultur
fibroblast
thu
method
increas
ang
express
may
exert
resist
effect
develop
pf
similar
express
express
ang
also
decreas
blm
treatment
current
studi
tiia
treatment
significantli
prevent
decreas
ang
express
compani
allevi
collagen
deposit
fibrosi
recent
studi
unfold
promis
pharmaceut
drug
treat
pf
ryo
et
al
show
newli
develop
drug
pirfenidon
exert
protect
effect
patient
mildtosever
andor
progress
ipf
though
long
way
go
seen
light
us
summari
present
studi
explor
protect
effect
mechan
tiia
pf
model
rat
tiia
may
exert
protect
effect
blm
induc
pf
axi
may
answer
protect
effect
present
studi
may
knowledg
offer
basic
inform
clinic
treat
strategi
pf
